| Trial Name: |
Oral Remodulin Treatment for Newly Diagnosed Patients with Pulmonary Hypertension
|
| Intro: |
|
| Condition: |
|
| Description: |
TDE-PH-302: A 12-Week, International, Multicenter, Double-Blind, Randomized, Placebo-Controlled Comparison of the Efficacy and Safety of Oral UT-15C Sustained Release Tablets in Subjects with Pulmonary Arterial Hypertension. Start: 08/2007 End: When enrollment is full |
| Criteria: |
|
| Contact: |
Please contact David Haney at (216) 844-2381. |
Participant Confidentiality:
All information regarding participation in Clinical Trials is treated with the
utmost confidentiality. University Hospitals Case Medical Center and the
Division of Clinical Research recognize and respect the confidentiality of this
information. Access to information related to clinical trials and their
participants is restricted to authorized clinical trials personnel only.
Back